In the past year, we have made several new transgenic mice lines. We recently made a reversible apoE KO mice using the Tet-Off system so that we can reversibly control the expression of apoE. In the absence of apoE, mice develop a profound dyslipidemia and atherosclerosis. We plan to use this model to examine the ability of several therapies to reverse atherosclerosis by restoring the expression of apoE while commencing the therapy. This should be a more relevant animal model compared to the commonly used atherosclerosis progression models for testing new cardiovascular therapies in reversing existing disease in humans. We also published 2 papers last year, describing a new transgenic animal models specifically expressing either ABCA1 or Arginase II in endothelial cells, using the Tie2 promoter. In the first model, we found that endothelial expression of ABCA1 only had a minor effect on circulating lipoprotein levels but was very effective in reducing the development of atherosclerosis. This study suggests an important role of ABCA1 in cholesterol efflux from endothelial cells. Arginase II overexpression in endothelial cells resulted in endothelial dysfunction and hypertension and markedly increased their propensity for atherosclerosis when on the apoE KO background. This study demonstrates the role of arginase II in depleting arginine levels for the production of NO and suggests that it may be a target for drug development.

Project Start
Project End
Budget Start
Budget End
Support Year
17
Fiscal Year
2012
Total Cost
$24,861
Indirect Cost
Name
National Heart, Lung, and Blood Institute
Department
Type
DUNS #
City
State
Country
Zip Code
Yang, Zhi-Hong; Gordon, Scott M; Sviridov, Denis et al. (2017) Dietary supplementation with long-chain monounsaturated fatty acid isomers decreases atherosclerosis and alters lipoprotein proteomes in LDLr(-/-) mice. Atherosclerosis 262:31-38
Gordon, Scott M; Remaley, Alan T (2017) High density lipoproteins are modulators of protease activity: Implications in inflammation, complement activation, and atherothrombosis. Atherosclerosis 259:104-113
Furumoto, Yasuko; Smith, Carolyne K; Blanco, Luz et al. (2017) Tofacitinib Ameliorates Murine Lupus and Its Associated Vascular Dysfunction. Arthritis Rheumatol 69:148-160
Sakurai, Toshihiro; Sakurai, Akiko; Chen, Ye et al. (2017) Dietary ?-cyclodextrin reduces atherosclerosis and modifies gut flora in apolipoprotein E-deficient mice. Mol Nutr Food Res 61:
Yang, Zhi-Hong; Bando, Masahiro; Sakurai, Toshihiro et al. (2016) Long-chain monounsaturated fatty acid-rich fish oil attenuates the development of atherosclerosis in mouse models. Mol Nutr Food Res 60:2208-2218
Sorokin, Alexander V; Yang, Zhi-Hong; Vaisman, Boris L et al. (2016) Addition of aspirin to a fish oil-rich diet decreases inflammation and atherosclerosis in ApoE-null mice. J Nutr Biochem 35:58-65
Thacker, Seth G; Zarzour, Abdalrahman; Chen, Ye et al. (2016) High-density lipoprotein reduces inflammation from cholesterol crystals by inhibiting inflammasome activation. Immunology 149:306-319
Ahmad, Faiyaz; Chung, Youn Wook; Tang, Yan et al. (2016) Phosphodiesterase 3B (PDE3B) regulates NLRP3 inflammasome in adipose tissue. Sci Rep 6:28056
Ossoli, Alice; Neufeld, Edward B; Thacker, Seth G et al. (2016) Lipoprotein X Causes Renal Disease in LCAT Deficiency. PLoS One 11:e0150083
Thacker, Seth G; Rousset, Xavier; Esmail, Safiya et al. (2015) Increased plasma cholesterol esterification by LCAT reduces diet-induced atherosclerosis in SR-BI knockout mice. J Lipid Res 56:1282-95

Showing the most recent 10 out of 40 publications